Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Echo Therapeutics Inc    

SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Delisting of Securities of BIND Therapeutics, Inc., InterCloud Systems, Inc., Echo Therapeutics, Inc., 1347 Capital Corp., and EPIRUS Biopharmaceuticals, Inc. from The Nasdaq Stock Market

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/24/2016 | 11:20am CEST

(GlobeNewswire) - The Nasdaq Stock Market announced today that it will delist the common stock of BIND Therapeutics, Inc. BIND Therapeutics, Inc.s stock was suspended on August 01, 2016 and has not traded on Nasdaq since that time.

Nasdaq also announced that it will delist the common stock and warrant of InterCloud Systems, Inc. InterCloud Systems, Incs common stock and warrant were suspended on August 31, 2016 and have not traded on Nasdaq since that time.

Nasdaq also announced that it will delist the common stock of Echo Therapeutics, Inc. Echo Therapeutics, Inc.s stock was suspended on July 12, 2016 and has not traded on Nasdaq since that time.

Nasdaq also announced that it will delist the common stock, warrant, unit and right of 1347 Capital Corp. 1347 Capital Corp.s common stock, warrant, unit and right were suspended on July 12, 2016 and have not traded on Nasdaq since that time.

Finally, Nasdaq announced that it will delist the common stock of EPIRUS Biopharmaceuticals, Inc. EPIRUS Biopharmaceuticals, Inc.s stock was suspended on August 04, 2016 and has not traded on Nasdaq since that time.

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delistings and whether the companies securities are trading on another venue, please review the companies public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaqs rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.

NDAQO

(c) 2016 Cihan News Agency. All right reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ECHO THERAPEUTICS INC
09/24 Delisting of Securities of BIND Therapeutics, Inc., InterCloud Systems, Inc.,..
08/25 ECHO THERAPEUTICS : Announces Second Quarter 2016 Financial Results
08/15 ECHO THERAPEUTICS : Announces Second Quarter 2016 Financial Results
07/13 OTC MARKETS : Welcomes Newly Verified OTCQB Companies
07/11 ECHO THERAPEUTICS : Fails The Test, OREX To Effect Reverse Split, PFE's S-TRAC S..
07/08 ECHO THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued ..
06/30 ECHO THERAPEUTICS : Begins Testing of NextGen CGM System Components
06/15 ECHO THERAPEUTICS : Announces Institutional Review Board (IRB) Approval of New P..
06/03 ECHO THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fi..
05/26 ECHO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (f..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
07/29DJSony Reports Surprise Profit
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
08/12 Echo Therapeutics reports Q2 results
08/10 Midday Gainers /Losers
08/08 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
07/12 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
07/11 Midday Gainers / Losers
Advertisement
Chart ECHO THERAPEUTICS INC
Duration : Period :
Echo Therapeutics Inc Technical Analysis Chart | US27876L2060 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Scott Wayne Hollander President, Chief Executive Officer & Director
Mike M. Goldberg Chairman
Thomas H. Bishop Vice President-Operations & Product Development
Alan Wayne Schoenbart Chief Financial Officer & Secretary
Shepard M. Goldberg Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ECHO THERAPEUTICS INC-16.20%8
THERMO FISHER SCIENTIF..11.15%62 159
BOSTON SCIENTIFIC CORP..28.58%32 263
PHILIPS12.92%28 328
INTUITIVE SURGICAL, IN..30.04%27 339
ILLUMINA, INC.-6.57%26 290
More Results